Strides Pharma
-
{
- All
- News
-
Strides Pharma Profit Rises 81% To Rs 114 Crore In June Quarter
Strides Pharma PAT rises 81 pc to Rs 114 cr in Jun qtr
-
Buy, Sell Or Hold: Strides Pharma, Bank Of India, Saregama India, Gulf Oil — Ask Profit
Markets analysts shared buy, sell and hold recommendations for an array of stocks on NDTV Profit's 'Ask Profit' show.
-
Strides Pharma Recalls Over 4.4 Lakh Cartons Of Testosterone Gel In US Market
Strides Pharma, Inc recalls over 4.4 lakh cartons of testosterone gel in US
-
Strides Pharma Arm OneSource Shares Debut At 6.9% Premium
OneSource received the final listing and trading approval for its equity shares from the NSE and the BSE on Jan. 22
-
Strides Pharma Arm OneSource Shares Debut At 6.9% Premium
OneSource received the final listing and trading approval for its equity shares from the NSE and the BSE on Jan. 22
-
Strides Pharma Share Price Rises Ahead Of CDMO OneSource's Listing On Jan. 24
OneSource received the final listing and trading approval for its equity shares from the NSE and the BSE on Jan. 22.
-
Strides Pharma's Arm Gets US FDA Approval For Pain Relief Tablets
Strides Pharma has received the approval for Acetaminophen and Ibuprofen over-the-counter tablets of 125 mg and 250 mg from the US FDA.
-
Stocks To Watch: Shriram Finance, Sammaan Capital, PC Jeweller, Vedanta, Embassy REIT
Godawari Power, Greaves Cotton, Strides Pharma, Grasim Industries and Indian Overseas Bank will be some of the other stocks to watch before going into trade on Thursday.
-
Strides Pharma Science Shareholders Allotted OneSource Equity In 2:1 Ratio
OneSource expects to receive listing approval from the stock exchanges during the fourth quarter of the ongoing fiscal.
-
Strides Pharma Q2 Results Review - U.S. Scaling To New Highs: ICICI Securities
The brokerage maintain our Buy rating on the stock with a higher target price of Rs 1,800.
-
Strides Pharma Q2 Results Review - U.S. Scaling To New Highs: ICICI Securities
The brokerage maintain our Buy rating on the stock with a higher target price of Rs 1,800.
-
Strides Pharma Unit Gets Investment Commitments Of Rs 801 Crore Ahead Of Planned Listing
Strides Pharma share price closed flat at Rs 1,565 apiece on Tuesday, compared to 0.28% decline in the benchmark Nifty 50.
-
Strides Pharma Unit Gets Investment Commitments Of Rs 801 Crore Ahead Of Planned Listing
Strides Pharma share price closed flat at Rs 1,565 apiece on Tuesday, compared to 0.28% decline in the benchmark Nifty 50.
-
Strides Pharma Gets FDA Nod For Generic Antidepressant Fluoxetine 60 Mg Tablet
The Bengaluru-based generic drugmaker will manufacture Fluoxetine tablets at a facility in Puducherry.
-
Strides Pharma Hits Nearly Nine-Year High After Dissolving US Arm
Authorities in New Jersey, US, liquidated the unit on Aug. 13. The exchange filing stated that Altima Innovations Inc. contributed Rs 5.52 lakh in net worth as of the last fiscal year 2024.
.jpg 2.jpg?downsize=260:146 "Strides Pharma Recalls Over 4.4 Lakh Cartons Of Testosterone Gel In US Market")
.jpg 2.jpg?downsize=260:146 "Strides Pharma Hits Nearly Nine-Year High After Dissolving US Arm")
-
Strides Pharma Profit Rises 81% To Rs 114 Crore In June Quarter
Strides Pharma PAT rises 81 pc to Rs 114 cr in Jun qtr
-
Buy, Sell Or Hold: Strides Pharma, Bank Of India, Saregama India, Gulf Oil — Ask Profit
Markets analysts shared buy, sell and hold recommendations for an array of stocks on NDTV Profit's 'Ask Profit' show.
-
Strides Pharma Recalls Over 4.4 Lakh Cartons Of Testosterone Gel In US Market
Strides Pharma, Inc recalls over 4.4 lakh cartons of testosterone gel in US
-
Strides Pharma Arm OneSource Shares Debut At 6.9% Premium
OneSource received the final listing and trading approval for its equity shares from the NSE and the BSE on Jan. 22
-
Strides Pharma Arm OneSource Shares Debut At 6.9% Premium
OneSource received the final listing and trading approval for its equity shares from the NSE and the BSE on Jan. 22
-
Strides Pharma Share Price Rises Ahead Of CDMO OneSource's Listing On Jan. 24
OneSource received the final listing and trading approval for its equity shares from the NSE and the BSE on Jan. 22.
-
Strides Pharma's Arm Gets US FDA Approval For Pain Relief Tablets
Strides Pharma has received the approval for Acetaminophen and Ibuprofen over-the-counter tablets of 125 mg and 250 mg from the US FDA.
-
Stocks To Watch: Shriram Finance, Sammaan Capital, PC Jeweller, Vedanta, Embassy REIT
Godawari Power, Greaves Cotton, Strides Pharma, Grasim Industries and Indian Overseas Bank will be some of the other stocks to watch before going into trade on Thursday.
-
Strides Pharma Science Shareholders Allotted OneSource Equity In 2:1 Ratio
OneSource expects to receive listing approval from the stock exchanges during the fourth quarter of the ongoing fiscal.
-
Strides Pharma Q2 Results Review - U.S. Scaling To New Highs: ICICI Securities
The brokerage maintain our Buy rating on the stock with a higher target price of Rs 1,800.
-
Strides Pharma Q2 Results Review - U.S. Scaling To New Highs: ICICI Securities
The brokerage maintain our Buy rating on the stock with a higher target price of Rs 1,800.
-
Strides Pharma Unit Gets Investment Commitments Of Rs 801 Crore Ahead Of Planned Listing
Strides Pharma share price closed flat at Rs 1,565 apiece on Tuesday, compared to 0.28% decline in the benchmark Nifty 50.
-
Strides Pharma Unit Gets Investment Commitments Of Rs 801 Crore Ahead Of Planned Listing
Strides Pharma share price closed flat at Rs 1,565 apiece on Tuesday, compared to 0.28% decline in the benchmark Nifty 50.
-
Strides Pharma Gets FDA Nod For Generic Antidepressant Fluoxetine 60 Mg Tablet
The Bengaluru-based generic drugmaker will manufacture Fluoxetine tablets at a facility in Puducherry.
-
Strides Pharma Hits Nearly Nine-Year High After Dissolving US Arm
Authorities in New Jersey, US, liquidated the unit on Aug. 13. The exchange filing stated that Altima Innovations Inc. contributed Rs 5.52 lakh in net worth as of the last fiscal year 2024.
